MedPath

Evaluation of the effect of bisoprolol in the control of atrial fibrillatio

Phase 3
Conditions
Atrial fibrillation in patients undergoing coronary artery bypass grafting.
Atrial fibrillation and flutter
Registration Number
IRCT20210121050095N1
Lead Sponsor
Qazvin University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
114
Inclusion Criteria

All patients with coronary heart disease are candidates for coronary heart surgery

Exclusion Criteria

History of previous atrial fibrillation
Having a permanent pacemaker
Any conclusive evidence of any ventricular or supra ventricular arrhythmia
Large left ventricle
Moderate to severe valvular heart disease
myocardial infarction
Lung disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath